Biofil Chemicals & Pharmaceuticals Shareholding

Biofil Chemicals & Pharmaceuticals Ltd Shareholding Pattern

The Biofil Chemicals & Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Biofil Chemicals & Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Biofil Chemicals & Pharmaceuticals Ltd (NSE: BIOFILCHEM, BSE: 524396) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Biofil Chemicals & Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Biofil Chemicals & Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Biofil Chemicals & Pharmaceuticals Ltd shareholding for Mar 2026 is:

• Promoters: 46.79%
• FII: 0%
• DII: 0.08%
• Public: 53.13%
• Government: 0%

Promoter holding in Biofil Chemicals & Pharmaceuticals Ltd remains stable, reflecting consistent long-term commitment.

Biofil Chemicals & Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Biofil Chemicals & Pharmaceuticals Ltd.

• Mar 2026: 46.79%
• Dec 2025: 46.79%
• Sept 2025: 46.79%
• Jun 2025: 46.82%
• Mar 2025: 46.82%

Promoter stake remains largely stable, showing consistent ownership structure.

Biofil Chemicals & Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Biofil Chemicals & Pharmaceuticals Ltd.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0.00%
• Jun 2025: 0.00%
• Mar 2025: 0.00%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Biofil Chemicals & Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0.08%
• Dec 2025: 0.08%
• Sept 2025: 0.08%
• Jun 2025: 0.08%
• Mar 2025: 0.08%

DII holdings remain stable, reflecting steady institutional participation.

Biofil Chemicals & Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 53.13%
• Dec 2025: 53.13%
• Sept 2025: 53.13%
• Jun 2025: 53.10%
• Mar 2025: 53.10%

Public holding remains stable with consistent retail participation.

Biofil Chemicals & Pharmaceuticals Ltd Government Holding

Government holding in Biofil Chemicals & Pharmaceuticals Ltd currently stands at 0%.

Biofil Chemicals & Pharmaceuticals Ltd operates without significant government ownership.

Biofil Chemicals & Pharmaceuticals Ltd Shareholding Analysis Summary

The Biofil Chemicals & Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Biofil Chemicals & Pharmaceuticals Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Biofil Chemicals & Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.